Previous Article | Next Article 
Molecular and Cellular Biology, August 2001, p. 5063-5070, Vol. 21, No. 15
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.15.5063-5070.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Apoptosis Triggered by Myc-Induced Suppression of
Bcl-XL or Bcl-2 Is Bypassed during
Lymphomagenesis
Christine M.
Eischen,1
David
Woo,2
Martine F.
Roussel,3,4 and
John L.
Cleveland1,3,*
Department of
Biochemistry1 and Department of Tumor
Cell Biology,4 St. Jude Children's Research
Hospital, Memphis, Tennessee 38105; Division of Nephrology,
Department of Medicine, University of California, Los Angeles, Los
Angeles, California 900952; and
Department of Biochemistry, University of Tennessee,
Memphis, Tennessee 381633
Received 2 November 2000/Returned for modification 19 December
2000/Accepted 1 May 2001
Enforced Bcl-2 expression inhibits Myc-induced apoptosis and
cooperates with Myc in transformation. Here we report that the synergy
between Bcl-2 and Myc in transforming hematopoietic cells in fact
reflects a Myc-induced pathway that selectively suppresses the
expression of the Bcl-XL or Bcl-2 antiapoptotic protein.
Myc activation suppresses Bcl-XL RNA and protein levels in
cultures of primary myeloid and lymphoid progenitors, and
Bcl-XL and Bcl-2 expression is inhibited by Myc in
precancerous B cells from Eµ-myc transgenic mice. The
suppression of bcl-X RNA levels by Myc requires de novo
protein synthesis, indicating that repression is indirect. Importantly,
the suppression of Bcl-2 or Bcl-XL by Myc is corrupted during Myc-induced tumorigenesis, as Bcl-2 and/or Bcl-XL
levels are markedly elevated in over one-half of all lymphomas arising in Eµ-myc transgenic mice. Bcl-2 and/or
Bcl-XL overexpression did not correlate with loss of ARF or
p53 function in tumor cells, indicating that these two apoptotic
pathways are inactivated independently. Therefore, the suppression of
Bcl-XL or Bcl-2 expression represents a physiological
Myc-induced apoptotic pathway that is frequently bypassed during lymphomagenesis.
*
Corresponding author. Mailing address: St. Jude
Children's Research Hospital, 332 N. Lauderdale, Memphis, TN 38105. Phone: (901) 495-2398. Fax: (901) 525-8025. E-mail:
john.cleveland{at}stjude.org.
Molecular and Cellular Biology, August 2001, p. 5063-5070, Vol. 21, No. 15
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.15.5063-5070.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Khuda, S. E., Loo, W. M., Janz, S., Van Ness, B., Erickson, L. D.
(2008). Deregulation of c-Myc Confers Distinct Survival Requirements for Memory B Cells, Plasma Cells, and Their Progenitors. J. Immunol.
181: 7537-7549
[Abstract]
[Full Text]
-
Garrison, S. P., Jeffers, J. R., Yang, C., Nilsson, J. A., Hall, M. A., Rehg, J. E., Yue, W., Yu, J., Zhang, L., Onciu, M., Sample, J. T., Cleveland, J. L., Zambetti, G. P.
(2008). Selection against PUMA Gene Expression in Myc-Driven B-Cell Lymphomagenesis. Mol. Cell. Biol.
28: 5391-5402
[Abstract]
[Full Text]
-
Nikiforov, M. A., Riblett, M., Tang, W.-H., Gratchouck, V., Zhuang, D., Fernandez, Y., Verhaegen, M., Varambally, S., Chinnaiyan, A. M., Jakubowiak, A. J., Soengas, M. S.
(2007). Tumor cell-selective regulation of NOXA by c-MYC in response to proteasome inhibition. Proc. Natl. Acad. Sci. USA
104: 19488-19493
[Abstract]
[Full Text]
-
Cheung, R. S.Y., Brooling, J. T., Johnson, M. M., Riehle, K. J., Campbell, J. S., Fausto, N.
(2007). Interactions between MYC and transforming growth factor alpha alter the growth and tumorigenicity of liver progenitor cells. Carcinogenesis
28: 2624-2631
[Abstract]
[Full Text]
-
Kawagoe, H., Kandilci, A., Kranenburg, T. A., Grosveld, G. C.
(2007). Overexpression of N-Myc Rapidly Causes Acute Myeloid Leukemia in Mice. Cancer Res.
67: 10677-10685
[Abstract]
[Full Text]
-
Truffinet, V., Pinaud, E., Cogne, N., Petit, B., Guglielmi, L., Cogne, M., Denizot, Y.
(2007). The 3' IgH Locus Control Region Is Sufficient to Deregulate a c-myc Transgene and Promote Mature B Cell Malignancies with a Predominant Burkitt-Like Phenotype. J. Immunol.
179: 6033-6042
[Abstract]
[Full Text]
-
Maclean, K. H., Kastan, M. B., Cleveland, J. L.
(2007). Atm Deficiency Affects Both Apoptosis and Proliferation to Augment Myc-Induced Lymphomagenesis. Mol Cancer Res
5: 705-711
[Abstract]
[Full Text]
-
Kelly, P. N., Puthalakath, H., Adams, J. M., Strasser, A.
(2007). Endogenous bcl-2 is not required for the development of E{micro}-myc induced B-cell lymphoma. Blood
109: 4907-4913
[Abstract]
[Full Text]
-
Bertwistle, D., Sherr, C. J.
(2007). Regulation of the Arf tumor suppressor in E{micro}-Myc transgenic mice: longitudinal study of Myc-induced lymphomagenesis. Blood
109: 792-794
[Abstract]
[Full Text]
-
Patel, J. H., McMahon, S. B.
(2007). BCL2 Is a Downstream Effector of MIZ-1 Essential for Blocking c-MYC-induced Apoptosis. J. Biol. Chem.
282: 5-13
[Abstract]
[Full Text]
-
Barbieri, E., Mehta, P., Chen, Z., Zhang, L., Slack, A., Berg, S., Shohet, J. M.
(2006). MDM2 inhibition sensitizes neuroblastoma to chemotherapy-induced apoptotic cell death.. Molecular Cancer Therapeutics
5: 2358-2365
[Abstract]
[Full Text]
-
Smith, D. P., Bath, M. L., Metcalf, D., Harris, A. W., Cory, S.
(2006). MYC levels govern hematopoietic tumor type and latency in transgenic mice. Blood
108: 653-661
[Abstract]
[Full Text]
-
Mo, H., Henriksson, M.
(2006). Identification of small molecules that induce apoptosis in a Myc-dependent manner and inhibit Myc-driven transformation. Proc. Natl. Acad. Sci. USA
103: 6344-6349
[Abstract]
[Full Text]
-
Patel, J. H., McMahon, S. B.
(2006). Targeting of Miz-1 Is Essential for Myc-mediated Apoptosis. J. Biol. Chem.
281: 3283-3289
[Abstract]
[Full Text]
-
Shiio, Y., Suh, K. S., Lee, H., Yuspa, S. H., Eisenman, R. N., Aebersold, R.
(2006). Quantitative Proteomic Analysis of Myc-induced Apoptosis: A DIRECT ROLE FOR Myc INDUCTION OF THE MITOCHONDRIAL CHLORIDE ION CHANNEL, mtCLIC/CLIC4. J. Biol. Chem.
281: 2750-2756
[Abstract]
[Full Text]
-
Talos, F., Petrenko, O., Mena, P., Moll, U. M.
(2005). Mitochondrially Targeted p53 Has Tumor Suppressor Activities In vivo. Cancer Res.
65: 9971-9981
[Abstract]
[Full Text]
-
Ho, J. S. L., Ma, W., Mao, D. Y. L., Benchimol, S.
(2005). p53-Dependent Transcriptional Repression of c-myc Is Required for G1 Cell Cycle Arrest. Mol. Cell. Biol.
25: 7423-7431
[Abstract]
[Full Text]
-
Cavin, L. G., Wang, F., Factor, V. M., Kaur, S., Venkatraman, M., Thorgeirsson, S. S., Arsura, M.
(2005). Transforming Growth Factor-{alpha} Inhibits the Intrinsic Pathway of c-Myc-Induced Apoptosis through Activation of Nuclear Factor-{kappa}B in Murine Hepatocellular Carcinomas. Mol Cancer Res
3: 403-412
[Abstract]
[Full Text]
-
Wang, J., Boxer, L. M.
(2005). Regulatory Elements in the Immunoglobulin Heavy Chain Gene 3'-Enhancers Induce c-myc Deregulation and Lymphomagenesis in Murine B Cells. J. Biol. Chem.
280: 12766-12773
[Abstract]
[Full Text]
-
Cardone, M., Kandilci, A., Carella, C., Nilsson, J. A., Brennan, J. A., Sirma, S., Ozbek, U., Boyd, K., Cleveland, J. L., Grosveld, G. C.
(2005). The Novel ETS Factor TEL2 Cooperates with Myc in B Lymphomagenesis. Mol. Cell. Biol.
25: 2395-2405
[Abstract]
[Full Text]
-
Slack, A., Chen, Z., Tonelli, R., Pule, M., Hunt, L., Pession, A., Shohet, J. M.
(2005). The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma. Proc. Natl. Acad. Sci. USA
102: 731-736
[Abstract]
[Full Text]
-
Ricci, M. S., Jin, Z., Dews, M., Yu, D., Thomas-Tikhonenko, A., Dicker, D. T., El-Deiry, W. S.
(2004). Direct Repression of FLIP Expression by c-myc Is a Major Determinant of TRAIL Sensitivity. Mol. Cell. Biol.
24: 8541-8555
[Abstract]
[Full Text]
-
Swanson, P. J., Kuslak, S. L., Fang, W., Tze, L., Gaffney, P., Selby, S., Hippen, K. L., Nunez, G., Sidman, C. L., Behrens, T. W.
(2004). Fatal Acute Lymphoblastic Leukemia in Mice Transgenic for B Cell-Restricted bcl-xL and c-myc. J. Immunol.
172: 6684-6691
[Abstract]
[Full Text]
-
Grassilli, E., Ballabeni, A., Maellaro, E., Del Bello, B., Helin, K.
(2004). Loss of MYC Confers Resistance to Doxorubicin-induced Apoptosis by Preventing the Activation of Multiple Serine Protease- and Caspase-mediated Pathways. J. Biol. Chem.
279: 21318-21326
[Abstract]
[Full Text]
-
Egle, A., Harris, A. W., Bouillet, P., Cory, S.
(2004). Bim is a suppressor of Myc-induced mouse B cell leukemia. Proc. Natl. Acad. Sci. USA
101: 6164-6169
[Abstract]
[Full Text]
-
Nilsson, J. A., Maclean, K. H., Keller, U. B., Pendeville, H., Baudino, T. A., Cleveland, J. L.
(2004). Mnt Loss Triggers Myc Transcription Targets, Proliferation, Apoptosis, and Transformation. Mol. Cell. Biol.
24: 1560-1569
[Abstract]
[Full Text]
-
Felix, K., Polack, A., Pretsch, W., Jackson, S. H., Feigenbaum, L., Bornkamm, G.-W., Janz, S.
(2004). Moderate Hypermutability of a Transgenic lacZ Reporter Gene in Myc-Dependent Inflammation-Induced Plasma Cell Tumors in Mice. Cancer Res.
64: 530-537
[Abstract]
[Full Text]
-
Silva, S., Kovalchuk, A. L., Kim, J. S., Klein, G., Janz, S.
(2003). BCL2 Accelerates Inflammation-induced BALB/c Plasmacytomas and Promotes Novel Tumors with Coexisting T(12;15) and T(6;15) Translocations. Cancer Res.
63: 8656-8663
[Abstract]
[Full Text]
-
Irvin, B. J., Wood, L. D., Wang, L., Fenrick, R., Sansam, C. G., Packham, G., Kinch, M., Yang, E., Hiebert, S. W.
(2003). TEL, a Putative Tumor Suppressor, Induces Apoptosis and Represses Transcription of Bcl-XL. J. Biol. Chem.
278: 46378-46386
[Abstract]
[Full Text]
-
Maclean, K. H., Keller, U. B., Rodriguez-Galindo, C., Nilsson, J. A., Cleveland, J. L.
(2003). c-Myc Augments Gamma Irradiation-Induced Apoptosis by Suppressing Bcl-XL. Mol. Cell. Biol.
23: 7256-7270
[Abstract]
[Full Text]
-
Tajiri, T., Liu, X., Thompson, P. M., Tanaka, S., Suita, S., Zhao, H., Maris, J. M., Prendergast, G. C., Hogarty, M. D.
(2003). Expression of a MYCN-interacting Isoform of the Tumor Suppressor BIN1 Is Reduced in Neuroblastomas with Unfavorable Biological Features. Clin. Cancer Res.
9: 3345-3355
[Abstract]
[Full Text]
-
Vallat, L., Magdelenat, H., Merle-Beral, H., Masdehors, P., Potocki de Montalk, G., Davi, F., Kruhoffer, M., Sabatier, L., Orntoft, T. F., Delic, J.
(2003). The resistance of B-CLL cells to DNA damage-induced apoptosis defined by DNA microarrays. Blood
101: 4598-4606
[Abstract]
[Full Text]
-
Sanchez-Beato, M., Sanchez-Aguilera, A., Piris, M. A.
(2003). Cell cycle deregulation in B-cell lymphomas. Blood
101: 1220-1235
[Abstract]
[Full Text]
-
Li, S., Takasu, T., Perlman, D. M., Peterson, M. S., Burrichter, D., Avdulov, S., Bitterman, P. B., Polunovsky, V. A.
(2003). Translation Factor eIF4E Rescues Cells from Myc-dependent Apoptosis by Inhibiting Cytochrome c Release. J. Biol. Chem.
278: 3015-3022
[Abstract]
[Full Text]
-
Klefstrom, J., Verschuren, E. W., Evan, G.
(2002). c-Myc Augments the Apoptotic Activity of Cytosolic Death Receptor Signaling Proteins by Engaging the Mitochondrial Apoptotic Pathway. J. Biol. Chem.
277: 43224-43232
[Abstract]
[Full Text]
-
Juin, P., Hunt, A., Littlewood, T., Griffiths, B., Swigart, L. B., Korsmeyer, S., Evan, G.
(2002). c-Myc Functionally Cooperates with Bax To Induce Apoptosis. Mol. Cell. Biol.
22: 6158-6169
[Abstract]
[Full Text]
-
Barrett, C. M., Lewis, F. L., Roaten, J. B., Sweatman, T. W., Israel, M., Cleveland, J. L., Lothstein, L.
(2002). Novel Extranuclear-targeted Anthracyclines Override the Antiapoptotic Functions of Bcl-2 and Target Protein Kinase C Pathways to Induce Apoptosis. Molecular Cancer Therapeutics
1: 469-481
[Abstract]
[Full Text]
-
Eischen, C. M., Rehg, J. E., Korsmeyer, S. J., Cleveland, J. L.
(2002). Loss of Bax Alters Tumor Spectrum and Tumor Numbers in ARF-deficient Mice. Cancer Res.
62: 2184-2191
[Abstract]
[Full Text]
-
Eischen, C. M., Roussel, M. F., Korsmeyer, S. J., Cleveland, J. L.
(2001). Bax Loss Impairs Myc-Induced Apoptosis and Circumvents the Selection of p53 Mutations during Myc-Mediated Lymphomagenesis. Mol. Cell. Biol.
21: 7653-7662
[Abstract]
[Full Text]